Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Cash (2020 - 2022)

Historic Change in Cash for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q4 2022 value amounting to $11.9 million.

  • Atea Pharmaceuticals' Change in Cash rose 11586.37% to $11.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$576.0 million, marking a year-over-year decrease of 57336.34%. This contributed to the annual value of -$79.1 million for FY2024, which is 7648.49% down from last year.
  • Atea Pharmaceuticals' Change in Cash amounted to $11.9 million in Q4 2022, which was up 11586.37% from -$508.1 million recorded in Q3 2022.
  • Atea Pharmaceuticals' Change in Cash's 5-year high stood at $744.7 million during Q4 2020, with a 5-year trough of -$508.1 million in Q3 2022.
  • For the 3-year period, Atea Pharmaceuticals' Change in Cash averaged around $13.9 million, with its median value being -$13.4 million (2020).
  • As far as peak fluctuations go, Atea Pharmaceuticals' Change in Cash skyrocketed by 32478.62% in 2021, and later tumbled by 227142.49% in 2022.
  • Atea Pharmaceuticals' Change in Cash (Quarter) stood at $744.7 million in 2020, then crashed by 110.11% to -$75.3 million in 2021, then soared by 115.86% to $11.9 million in 2022.
  • Its last three reported values are $11.9 million in Q4 2022, -$508.1 million for Q3 2022, and -$21.1 million during Q2 2022.